SPATA13

protein-coding

spermatogenesis associated 13, the group of Pleckstrin homology domain containing|MicroRNA protein coding host genes|Dbl family Rho GEFs

Gene summary

Enables guanyl-nucleotide exchange factor activity and identical protein binding activity. Involved in cell migration; plasma membrane bounded cell projection assembly; and regulation of cell migration. Located in several cellular components, including filopodium; lamellipodium; and ruffle membrane. [provided by Alliance of Genome Resources, Jul 2025]

MANE transcript

NM_001166271.3

Inheritance

AD

ClinVar variants

U:209B:30

Top phenotype

SPATA13-related disorder

gnomAD constraint

pLI —, LoF o/e 0.3

Max pathogenic AF

—

Genomic locus

chr13:23,979,810-24,035,027

External References & Databases

Transcript & Mutation Effects

hg38 • Region Span ~55.2 kb
Loading mutation effect viewer...

GenCC Phenotypes & Disease Associations

Curated gene-disease validity assertions and inheritance patterns

primary angle-closure glaucomaLIMITED

Inheritance Pattern: AD

Disease ID:MONDO:0001868

Submitter: ClinGen

*SPATA13* was first reported in relation to autosomal dominant primary angle closure glaucoma (PACG) in 2020 (Waseem et al., PMID: 32339198). PACG disorders include physical obstruction of the aqueous humor outflow channels, elevation of internal eye pressure, ocular hypertension, plateau iris configuration, iridocorneal angle closure, drainage angle damage, and end-organ glaucomatous damage. *SPATA13 *contains 1,339 amino acids and 14 exons, and functions as a guanine nucleotide exchange factor. There is only one disease assertion made for *SPATA13*; Primary Angle Closure Glaucoma (618880). Summary of Genetic Evidence (2.1 points): One 9-base-pair deletion was found in all affected individuals (n=12) from one family in one publication (PMID: 32339198). The mechanism of pathogenicity appears to be loss of function. Summary of Experimental Evidence (0 points): This gene-disease relationship is supported by an expression study (PMID: 32339198) revealing expression of SPATA13 in eye tissue including the human iris, ciliary epithelium, retinal pigment epithelium, retina and lens; however, the study also suggested a ubiquitous expression pattern of *SPATA13,* confirmed by GTex (https://gtexportal.org/home/gene/SPATA13). In summary, there is limited evidence to support this gene-disease relationship. Although more evidence is needed to support a causal role, no convincing evidence has emerged that contradicts the gene-disease relationship.

primary angle-closure glaucomaMODERATE

Inheritance Pattern: AD

Disease ID:MONDO:0001868

Submitter: PanelApp Australia

ClinVar Associated Diseases & Phenotypes

Reported disease conditions connected to SPATA13 variants in ClinVar

3 Conditions Cataloged
not specifiedTotal: 214
SPATA13-related disorderTotal: 20
not providedTotal: 1

ClinVar Variants & Pathogenicity by Type

Statistics based on transcript NM_001166271.3. Only rare variants are included.

We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.

Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
2
clinvar
10
clinvar
12
missense
206
clinvar
17
clinvar
3
clinvar
226
nonsense
0
start loss
0
frameshift
0
splice donor/acceptor (+/-2bp)
1
clinvar
1
Total00209273239
Loading ClinVar variants...

Transcript Catalog

Annotated transcript isoforms across RefSeq and Ensembl databases

Showing 4 of 23 transcripts
Transcript IDSourceProtein IDCoding ExonsMANE Status
NM_001166271.3RefSeqNP_001159743.112MANE Select
ENST00000382108.8EnsemblENSP00000371542.312MANE Select
NM_001286792.2RefSeqNP_001273721.114Standard
NM_001286793.2RefSeqNP_001273722.19Standard

Gene Ontology (GO) Annotations & Pathways

Biological processes, molecular functions, cellular components and pathways

Pathways ConsensusPathDB

  • Regulation of actin cytoskeleton - Homo sapiens (human)
  • Regulation of RAC1 activity
  • Regulation of CDC42 activity

Biological Process

  • cell migration
  • lamellipodium assembly
  • regulation of cell migration
  • regulation of Rho protein signal transduction
  • filopodium assembly

Molecular Function

  • guanyl-nucleotide exchange factor activity
  • protein binding
  • Rac guanyl-nucleotide exchange factor activity

Cellular Component

  • nucleoplasm
  • cytoplasm
  • cytosol
  • lamellipodium
  • filopodium

gnomAD Constraint

Source: gnomAD

Gene type
protein_coding
Transcript type
protein_coding
Transcript
ENST00000424834
Coding exons
12
Length
327269
Individuals with no LoFs
125720
Homozygous LoFs
0
Heterozygous LoFs
28
Defined
125748
p
0.000111
Z-ScoreObservedExpectedObserved/ExpectedMutation RateTotal Possible
Missense2.036367970.7980.00005008391
Missense (PolyPhen)147248.910.590572629
Synonymous1.782883290.8750.00002172551
Loss of Function4.501447.40.2950.00000235552

Population LoF Frequency

PopulationCAFp-valueStatus
African0.0000620.000062rare
Latino/Admixed American00.0absent
Ashkenazi Jewish0.000300.00030rare
East Asian0.0000540.000054rare
Finnish0.000140.00014rare
European (Non-Finnish)0.000160.00016rare
South Asian0.0000330.000033rare
Other0.000160.00016rare

dbNSFP Gene Annotations

Source: dbNSFP

Function
FUNCTION: Acts as guanine nucleotide exchange factor (GEF) for RHOA, RAC1 and CDC42 GTPases. Regulates cell migration and adhesion assembly and disassembly through a RAC1, PI3K, RHOA and AKT1-dependent mechanism. Increases both RAC1 and CDC42 activity, but decreases the amount of active RHOA. Required for MMP9 up- regulation via the JNK signaling pathway in colorectal tumor cells. Involved in tumor angiogenesis and may play a role in intestinal adenoma formation and tumor progression. {ECO:0000269|PubMed:17145773, ECO:0000269|PubMed:17599059, ECO:0000269|PubMed:19151759, ECO:0000269|PubMed:19893577, ECO:0000269|PubMed:19934221}.;

Recessive Scores

pRec
0.112

Intolerance Scores

LoFtool
0.257
RVIS EVS
2.01
RVIS percentile EVS
97.67

Essentials

Essential (CRISPR)
N
Essential (CRISPR2)
N
Essential (gene trap)
N
Indispensability pred.
N
Indispensability score
0.214

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.